Changes over time in cardiovascular and respiratory morbidity
Starting period | Change from start to end period | ||||
Period | Prevalence | End period | Raw change | Adj. change* (Adj. change 95% CI) | |
Blood pressure/cholesterol | |||||
High blood pressure LSI | 1994–1996 | 2.7% | 2011–14 | 1.3% | 1.0% (0.4% to 1.6%) |
Recent high blood pressure | 1994–1996 | 4.2% | 2011–14 | 5.2% | 4.8% (3.9% to 5.6%) |
Biomarker high BP | 1994–1996 | 8.4% | 2011–14 | −4.7% | −5.0% (−5.6% to −4.5%) |
High total cholesterol | 1994–1996 | 75.7% | 2011–14 | −16.4% | −17.6% (−19.1% to −16.1%) |
Low HDL cholesterol | 1997–2000 | 11.8% | 2011–14 | −8.0% | −8.0% (−9.0% to −7.1%) |
Other CVD | |||||
Recent heart attack/stroke | 1994–1996 | 1.2% | 2011–14 | −0.3% | −0.4% (−0.7% to 0.0%) |
Recent angina | 1994–1996 | 1.1% | 2011–14 | −0.4% | −0.5% (−0.8% to −0.1%) |
IHD/stroke LSI | 1994–1996 | 1.4% | 2011–14 | −0.4% | −0.6% (−0.9% to −0.2%) |
Heart attack symptoms | 1994–1996 | 5.5% | 2011–14 | −0.3% | −0.5% (−1.3% to 0.3%) |
Mini stroke (TIA) symptoms | 2001–2003 | 8.1% | 2011–14 | −1.4% | −1.4% (−2.4% to −0.4%) |
Angina symptoms | 1994–1996 | 2.3% | 2011–14 | −1.1% | −1.2% (−1.6% to −0.7%) |
Any CVD LSI | 1994–1996 | 5.8% | 2011–14 | 1.1% | 0.6% (−0.1% to 1.4%) |
Any recent CVD | 1994–1996 | 3.1% | 2011–14 | 0.7% | 0.5% (−0.1% to 1.2%) |
Respiratory | |||||
Lifetime diagnosed asthma | 1994–1996 | 11.2% | 2008–10 | 5.5% | 5.7% (4.5% to 6.8%) |
Asthma LSI | 1994–1996 | 5.0% | 2011–14 | 0.7% | 0.7% (0.0% to 1.4%) |
Breathlessness-grade 2+ | 1994–1996 | 19.7% | 2008–10 | −4.4% | −4.8% (−6.1% to −3.5%) |
Breathlessness-grade 3 | 1994–1996 | 7.8% | 2008–10 | −1.4% | −1.6% (−2.5% to −0.8%) |
Recent wheezing/asthma | 1994–1996 | 19.5% | 2008–10 | −1.2% | −1.2% (−2.5% to 0.1%) |
Wheezing stopping sleep | 1994–1996 | 3.6% | 2008–10 | −0.4% | −0.5% (−1.0% to 0.1%) |
COPD symptoms | 1994–1996 | 6.6% | 2008–10 | −1.5% | −1.6% (−2.3% to −0.8%) |
See table 1 for details on LSI.
Red text indicates negative values.
*‘Adj.’ = adjusted for changing age and sex distribution of the working-age population.
BP, blood pressure; CVD, cardiovascular disease; HDL, high density lipoprotein; IHD, ischaemic heart disease; LSI, longstanding illness.